James R Anderson Selected Research

James R Anderson Research Topics

Disease

30	Rhabdomyosarcoma 11/2019 - 06/2002
22	Neoplasms (Cancer) 01/2021 - 06/2002
10	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 01/2002
10	Wilms Tumor (Wilm's Tumor) 10/2020 - 10/2009
4	Osteoarthritis 12/2021 - 01/2019
4	Sepsis (Septicemia) 01/2019 - 06/2007
4	Disease Progression 01/2019 - 09/2010
4	Embryonal Rhabdomyosarcoma 06/2017 - 04/2011
3	Anaplasia 01/2018 - 05/2011
3	Infections 11/2012 - 06/2007
3	Coronary Artery Disease (Coronary Atherosclerosis) 09/2005 - 12/2004
2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2019
2	Retinal Degeneration 01/2019 - 07/2007
2	Neoplasm Metastasis (Metastasis) 01/2018 - 10/2012
2	Ganglion Cysts (Ganglion) 04/2013 - 07/2007
2	Cross Infection (Nosocomial Infection) 11/2012 - 01/2008
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2005 - 02/2003
1	Hypoxia (Hypoxemia) 09/2022
1	Rheumatoid Arthritis 03/2022
1	Polyps 01/2022
1	Cadaver (Cadavers) 12/2021
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2021
1	Clear Cell Sarcoma 01/2019
1	Osteochondrosis (Osgood Schlatter Disease) 01/2019
1	Joint Diseases (Joint Disease) 01/2019
1	Sclerosis 11/2018
1	Residual Neoplasm 08/2015
1	Central Nervous System Diseases (CNS Diseases) 08/2015

Drug/Important Bio-Agent (IBA)

13	Vincristine (Oncovin)FDA LinkGeneric 10/2020 - 01/2008
11	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2020 - 09/2004
9	Dactinomycin (Actinomycin)FDA LinkGeneric 01/2018 - 11/2009
8	Biomarkers (Surrogate Marker)IBA 03/2022 - 04/2013
8	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 07/2006
6	Etoposide (VP 16)FDA LinkGeneric 10/2020 - 07/2006
5	Ifosfamide FDA LinkGeneric 01/2021 - 07/2006
4	Irinotecan (Camptosar)FDA LinkGeneric 10/2020 - 10/2010
3	Proteins (Proteins, Gene)FDA Link 03/2022 - 09/2010
3	Dobutamine FDA LinkGeneric 09/2005 - 12/2004
2	Blood Proteins (Serum Proteins)IBA 03/2022 - 09/2010
2	Peptides (Polypeptides)IBA 03/2022 - 01/2019
2	ProteomeIBA 03/2022 - 01/2019
2	Retinaldehyde (Retinal)IBA 01/2021 - 01/2019
2	pembrolizumabIBA 01/2020 - 01/2019
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2019
2	Glutamic Acid (Glutamate)FDA Link 01/2018 - 07/2007
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2018 - 04/2013
2	Biological ProductsIBA 01/2017 - 03/2010
2	Rituximab (Mabthera)FDA Link 08/2015 - 11/2014
2	MyogeninIBA 05/2014 - 07/2013
1	Apolipoproteins MIBA 03/2022
1	Apolipoprotein C-IIIIBA 03/2022
1	Apolipoprotein C-I (Apolipoprotein C1)IBA 03/2022
1	Liver X ReceptorsIBA 03/2022
1	Rheumatoid FactorIBA 03/2022
1	Anti-Citrullinated Protein AntibodiesIBA 03/2022
1	Selenoprotein PIBA 03/2022
1	Complement C4b-Binding ProteinIBA 03/2022
1	Retinoid X Receptors (Retinoid X Receptor)IBA 03/2022
1	Lysine Carboxypeptidase (Carboxypeptidase N)IBA 03/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2022
1	Oncogene Proteins (Oncogene Protein)IBA 03/2022
1	N-Acetylmuramoyl-L-alanine Amidase (Autolysin)IBA 03/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2022
1	PolymersIBA 01/2022
1	PolyphosphatesIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 12/2021
1	AmmoniaIBA 12/2021
1	PutrescineIBA 12/2021
1	salicylhydroxamic acid (SHAM)IBA 12/2021
1	Carboplatin (JM8)FDA LinkGeneric 10/2020
1	temsirolimus FDA Link 11/2019
1	Bevacizumab (Avastin)FDA Link 11/2019
1	cixutumumabIBA 01/2019
1	Cytidine Monophosphate (CMP)IBA 01/2019
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2019
1	Insulin-Like Growth Factor Binding Protein 6IBA 01/2019
1	Temozolomide (Temodar)FDA LinkGeneric 01/2019
1	epacadostatIBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	LactoferrinIBA 01/2019
1	LigandsIBA 01/2019
1	Taurine FDA Link 11/2018
1	Phosphocreatine (Neoton)IBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Glutamine (L-Glutamine)FDA Link 01/2018
1	Pyruvic Acid (Pyruvate)IBA 01/2018
1	Citric Acid (Citrate)FDA LinkGeneric 01/2018
1	glycylproline (Gly-Pro)IBA 01/2018
1	Valine (L-Valine)FDA Link 01/2018
1	Alanine (L-Alanine)FDA Link 01/2018
1	Acetates (Acetic Acid Esters)FDA Link 01/2018
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2018
1	CreatinineIBA 01/2018

Therapy/Procedure

21	Therapeutics 10/2020 - 06/2002
16	Drug Therapy (Chemotherapy) 01/2021 - 01/2002
15	Radiotherapy 01/2021 - 06/2002
6	Nephrectomy 01/2018 - 06/2010
2	Critical Care (Surgical Intensive Care) 11/2012 - 06/2007
2	Induction Chemotherapy 09/2010 - 11/2007
1	Euthanasia (Mercy Killing) 09/2022